Transaction Valued at Over $96,000
LIVINGSTON, N.J., Dec. 11 /PRNewswire-FirstCall/ -- MM2 Group, Inc. (OTC Bulletin Board: MMGP) announced today that its wholly-owned subsidiary, Genotec Nutritionals, Inc., a New York based nutraceutical company which generates its sales from the distribution of its branded products and through custom formulations for several large strategic partners, has closed on a large order for a new product featuring high potency odorless fish oil and Coenzyme Q10 (CoQ10).
The transaction is valued at over $96,000. The order is expected to be the first of two orders from this customer, with the second order coming within the next 120 days.
Fish oil is known for being rich in unsaturated fatty acids and provides essential Omega-3 fatty acids (EPA and DHA). Fish oil may help reduce or inhibit risk factors involved in cardiovascular disease, cognitive decline, macular degeneration, as well as inflammatory and immune disorders. Omega-3 fatty acids also help prevent menopausal symptoms, promotes better circulation and neural development, and lowers cholesterol and triglycerides.
Coenzyme Q10 (CoQ10) is produced by the human body and is necessary for the basic functioning of cells. CoQ10 plays a key role in producing energy in the mitochondria, the part of a cell responsible for the production of energy in the form of ATP. CoQ10 levels are reported to decrease with age and to be low in patients with some chronic diseases such as heart conditions, muscular dystrophies, Parkinson's disease, cancer, diabetes, and HIV/AIDS. Some prescription drugs, like statins, may also lower CoQ10 levels.
Mark Meller, CEO of MM2 Group, stated, "We are pleased to announce the
closing of this sale. While the size is small relative to some of the other
transactions we've recently announced, I felt it was important to
communicate to our shareholders that we are doing business every day. We
are not just looking fo
|SOURCE MM2 Group, Inc.|
Copyright©2007 PR Newswire.
All rights reserved